Introduction
============

The glucocorticoid receptor (GR) belongs to the superfamily of the hormone-activated intracellular transcription factors, the nuclear hormone receptors (NHRs). Most of the biological effects of glucocorticoids are mediated through the GR and occur at the level of regulation of gene transcription ([@b26-btt-2-845]; [@b5-btt-2-845]; [@b109-btt-2-845]). The role of the GR, which acts in a ligand-, cell type-, and promoter-specific manner is important in the transcriptional activation of genes involving the regulated assembly of multiprotein complexes on enhancers and promoters ([@b89-btt-2-845]; [@b51-btt-2-845]; [@b78-btt-2-845]). The classical mechanism of steroid/hormone action ([Figure 1](#f1-btt-2-845){ref-type="fig"}) ([@b22-btt-2-845]; [@b52-btt-2-845]; [@b71-btt-2-845]; [@b64-btt-2-845]) states that the GR in its inactive form is located in the cytoplasm, and after entry into the cell the steroid/hormone finds the receptor as part of a large heteromeric complex consisting of several proteins including HSP90, HSP70, Immunophilins, FKBPs, CyP-40, P23, and possibly others ([@b39-btt-2-845]; [@b85-btt-2-845]; [@b75-btt-2-845], [@b76-btt-2-845]; [@b88-btt-2-845]; [@b87-btt-2-845]; [@b20-btt-2-845]; [@b68-btt-2-845]). Steroid binding leads to the disassembling of the complex through conformational changes in the receptor molecule and the activated receptor enters the nucleus, where it interacts with critical regulatory sites on the relevant genes ([@b37-btt-2-845]; [@b72-btt-2-845]; [@b35-btt-2-845]; [@b38-btt-2-845]; [@b91-btt-2-845]; [@b57-btt-2-845]; [@b110-btt-2-845]; [@b63-btt-2-845]; [@b53-btt-2-845]; [@b78-btt-2-845]; [@b104-btt-2-845], [@b105-btt-2-845]). The classic model for steroid action states that the DNA bound receptor collects a variety of ancillary factors which modify chromatin structure and/or contact the primary transcription complex machinery proteins such that transcription from the relevant promoter can be either enhanced or repressed. However, this has led to the problem of understanding how the receptor molecule makes such large protein surface areas available to accommodate specific sites for all these factors. The molecular mechanisms to explain this phenomenon have not been fully defined.

There are possibilities that some of these actions can be explained on the basis of post-translational modifications of specific NHRs. In spite of the fact that GR is a hormone-activated transcription factor, its expression and many physiological activities are highly regulated by post-translational modifications ([@b103-btt-2-845]; [@b45-btt-2-845]; [@b98-btt-2-845]; [@b56-btt-2-845]; [@b95-btt-2-845]). One such important post-translational modification associated with GR function is site-specific phosphorylation ([@b101-btt-2-845]; [@b42-btt-2-845]; [@b24-btt-2-845]). Involvement of several known phosphorylation sites in the GR and variety of kinases facilitates integration between cell-signaling pathways and the GR action ([@b49-btt-2-845]; [@b79-btt-2-845]). Most, if not all known phosphorylation sites in the GR are localized within the N-terminal domain (NTD) that contains a major transactivation domain, AF1 ([@b11-btt-2-845], [@b10-btt-2-845]; [@b7-btt-2-845]; [@b54-btt-2-845]).

Post-translational modifications including phosphorylation are generally an important phenomenon in regulation of protein function in eukaryotic cells, and are often concerned with switching of a cellular activity from one state to another ([@b2-btt-2-845]; [@b73-btt-2-845]; [@b50-btt-2-845]). It is now well accepted that for several transcription factors including GR, site-specific phosphorylation can modulate their DNA binding affinity, the interaction of transactivation domains of these transcription factors with components of the transcription initiation complex, and the shuttling of transcription factors between the cytoplasmic compartments ([@b3-btt-2-845]; [@b80-btt-2-845]; [@b99-btt-2-845]; [@b31-btt-2-845]). There are several reports showing that kinases can phosphorylate GR at multiple sites leading to altered GR activity ([@b7-btt-2-845]; [@b42-btt-2-845]). Depending upon the kinases involved, the GR activity can be both up- or down-regulated ([@b42-btt-2-845]). For example, phosphorylation of GR by cyclin-dependent kinases (Cdk1, Cdk2, and cdk5) leads to up regulate GR activity ([@b42-btt-2-845]; [@b104-btt-2-845]), whereas JNK and GSK3 inhibits GR activity through direct phosphorylation of GR ([@b79-btt-2-845], [@b80-btt-2-845]). In contrast, certain kinases such as p38 MAPK are reported to both up- and down-regulate GR activity, these effects of p38 MAPK appears to be cell-specific ([@b92-btt-2-845]; [@b67-btt-2-845]).

Some of the GR phosphorylation sites are conserved across species, whereas others are unique to specific species ([@b42-btt-2-845]). Generally, GR phosphorylation is ligand-dependent, which suggests that this may be a determinant of promoter specificity, interaction with coregulatory proteins, and even GR stability ([@b103-btt-2-845]; [@b112-btt-2-845]; [@b27-btt-2-845]). There are several kinases that phosphorylate the GR with the resultant phosphorylation enhancing GR transcriptional activity ([@b42-btt-2-845]). However, GR can also be phosphorylated in a ligand independent manner as well ([@b42-btt-2-845], [@b43-btt-2-845]). In fact, we have earlier shown that p38 MAPK can phosphorylate human GR fragment lacking the LBD, which enhances the transactivation activity of the GR and mediates GR-dependent apoptosis in cells transfected with this fragment ([@b67-btt-2-845]). We also found that p38 was activated probably through immediate upstream activators, MKK3 and MKK6, both specific to p38 ([@b67-btt-2-845]). In addition, MKK4, whose best-known substrate is JNK, can also phosphorylate p38. In recent years, it is becoming clearer that many receptor phosphorylation sites are substrates for multiple kinases, suggesting towards potential for very complex regulatory patterns. In this review article, we have summarized knowledge regarding the role of GR phosphorylation in the regulation of receptor function, and the possible underlying mechanisms of action.

The structural arrangements of the glucocorticoid receptor (GR)
===============================================================

The GR protein consists of a domain structure arrangement, typical of the superfamily of the NHRs ([@b109-btt-2-845]; [@b26-btt-2-845]; [@b5-btt-2-845]; [@b89-btt-2-845]; [@b51-btt-2-845]). This modular conceptual framework has been useful, but it has become clear that there are certain limits to the domain. This fundamental domain model divides the primary sequence into NTD, DNA-binding domain (DBD) ([@b34-btt-2-845]; [@b59-btt-2-845]), and LBD with "activation function" (AF2) sub-domain that regulates transcription ([@b30-btt-2-845]; [@b37-btt-2-845]; [@b9-btt-2-845]; [@b41-btt-2-845]; [@b65-btt-2-845]; [@b6-btt-2-845]). Ligand binding to the LBD results in conformational rearrangement of its AF2 sub-domain (usually helix 12) such that its surfaces are available for interactions with specific coregulatory proteins through LXXLL motifs. The GR and several other receptors in the family have long NTD ([@b53-btt-2-845]). In these is found another, potent transactivation domain, AF1 ([@b33-btt-2-845]; [@b66-btt-2-845]). Cooperative binding and site specificity combine for GR:GRE tethering allows receptor's interaction with the transcription initiation complex, directly by interactions between AF1/AF2 and the complex, or indirectly through specific coregulators ([@b94-btt-2-845]). To a first approximation, this conceptual model is useful, but fails to explain several essential facts such as the role of post-transcriptional modifications, including sumoylation, acetylation, and site-specific phosphorylation. Our recent data and available literature from other laboratories clearly indicate an important role of GR phosphorylation and involvement of specific kinases ([@b79-btt-2-845]; [@b42-btt-2-845]; [@b67-btt-2-845]). Other data suggests that intramolecular signaling occurs as well between the amino-terminal and LBD regions ([@b41-btt-2-845]; [@b36-btt-2-845]; [@b93-btt-2-845]; [@b51-btt-2-845]; [@b12-btt-2-845]). To fully understand the mechanisms of action of the GR, we must understand the answer to the above mentioned fundamental questions.

Phosphorylation regulates structure and functions of the GR
===========================================================

Like many other transcription factors, the GR is a phosphoprotein, which becomes hyperphosphorylated upon steroid binding, and it has been suggested that phosphorylation plays an important role in the regulation of GR activity ([@b42-btt-2-845]). Protein phosphorylation is generally an important regulatory mechanism for protein function in eukaryotic cells, and is often concerned with switching of a cellular activity from one state to another. Phosphorylation of the Pol II protein complex is correlated with the transition between transcriptional initiation and elongation ([@b71-btt-2-845]; [@b74-btt-2-845]); thus phosphorylation may be involved in transcriptional regulation. In recent years, more and more evidence point towards the role of phosphorylation and other post-translational modifications in the gene expression and regulation of many transcription factors ([@b13-btt-2-845]; [@b70-btt-2-845]; [@b106-btt-2-845]).

Cellular kinases play a prominent regulator role for the NHR ([@b42-btt-2-845]). Ligand binding, nuclear translocations, modulation of binding to REs, receptor dimerization, and interaction with general transcription factors, have all been linked to phosphorylation ([@b42-btt-2-845]). It has been reported that kinases enhance the transactivation activity of several steroid receptors both in a ligand-dependent and ligand-independent manner ([@b80-btt-2-845]; [@b42-btt-2-845]). For transcription factors, three main mechanisms of regulation by phosphorylation can be identified; 1) the DNA binding affinity of transcription factors can be modulated negatively or positively; 2) the interaction of transactivation domains of transcription factors with components of the transcription initiation complex can be affected; and 3) the shuttling of transcription factors between the cytoplasmic compartments can be influenced.

In the human GR five serine residues (S113, S141, S203, S211, and S226) have been identified ([@b42-btt-2-845]), whereas in the mouse GR there are eight phosphorylation residues identified. In mice, seven of the 8 phosphorylation sites are at serine residues (S122, S150, S212, S220, S234, S315, and S412) and one at threonine (T159) ([@b11-btt-2-845]; [@b10-btt-2-845]; [@b79-btt-2-845]). All the known phosphorylation sites identified in mouse GR are found in the NTD, in or near the AF1 domain ([@b62-btt-2-845]). Several kinases are reported to be involved in the phosphorylation of these sites, such as mitogen protein kinases (MAPK), cyclin-dependent kinase (CDK) ([@b49-btt-2-845]), glycogen synthase kinase-3 (GSK-3), and c-Jun N-terminal kinases (JNK) ([@b79-btt-2-845]). Though, each of these kinases is reported to show distinct specificities for potential phosphorylation residues, full receptor activity may require synergistic effects of these kinases and their signaling cascades.

In the human GR AF1, major functionally important known phosphorylated residues are S203, S211, and S226 (ure 2). At least two of these (S211 and S226) are thought to be important for transcriptional activity of the GR ([@b80-btt-2-845]; [@b42-btt-2-845]; [@b67-btt-2-845]). The use of site-specific antibodies has shown that S203 phosphorylation is involved in the GR translocation ([@b42-btt-2-845]). It has also shown that site-specific (S211) phosphorylation of the GR AF1 enhances its interaction with a protein from the DRIP/TRIP complex, and subsequently GR activity ([@b7-btt-2-845]; [@b42-btt-2-845]). These observations clearly suggest that site-specific phosphorylation in GR AF1 may regulate GR function, in an AF1-dependent manner. However, it is not yet known exactly how phosphorylation influences the structure and functions of the GR AF1.

The AF1 can act constitutively in the absence of LBD, and is quite active in stimulating transcription from simple promoters containing cognate binding sites(s). Because GR AF1 exists in intrinsically disordered conformation(s), advances in understanding its structure and functions have been slowed ([@b19-btt-2-845]; [@b4-btt-2-845]; [@b55-btt-2-845]). It is known that for function AF1 interacts with specific coregulatory proteins such as CBP, TBP, TIF2, DRIP/TRAP, Ada among others, and the available data strongly suggest that AF1 must adopt an ordered conformation to optimize interactions and subsequent transcriptional activity ([@b53-btt-2-845]). In recent years, it has become quite evident that eukaryotic genomes are highly enriched in intrinsically disorder proteins relative to prokaryotes, reflecting the greater need for signaling and regulation in nucleated cells ([@b18-btt-2-845]; [@b69-btt-2-845]; [@b25-btt-2-845]; [@b40-btt-2-845]; [@b96-btt-2-845]; [@b82-btt-2-845]; [@b102-btt-2-845]; [@b58-btt-2-845]). These disordered protein regions/domains promote molecular recognition primarily through unique combination of high specificity and low binding affinity with their functional binding partners, recognize and bind a number of biological targets, and create propensity to form large interaction surfaces suitable for interactions with their specific binding partners ([@b18-btt-2-845]; [@b69-btt-2-845]; [@b40-btt-2-845]; [@b25-btt-2-845]; [@b96-btt-2-845]; [@b82-btt-2-845]; [@b102-btt-2-845]; [@b58-btt-2-845]). We hypothesize that site-specific phosphorylation of the GR AF1 leads to changes in its conformations that are important for AF1's interaction with other critical coregulatory proteins, and subsequent transcriptional activity.

There are also reports suggesting that phosphorylation may affect GR stability and thus alter transcriptional activity of the receptor ([@b112-btt-2-845]). Co-transfection data from Cidlowski and colleagues ([@b103-btt-2-845]; [@b98-btt-2-845]) have shown that phosphorylated mouse GR had a half-life of 8--9 h in the presence of agonist, whereas mutations of multiple GR phosphorylation sites increased its half-life to 32 h. All the GR phosphorylation sites that are conserved among human, mouse, and rat are located within the AF1 domain. Single mutations of these do not alter receptor activity in an MMTV-driven promoter-reporter construct, but a GR lacking all five sites that are well conserved in mouse, rat and human GR shows significantly decreased activity ([@b1-btt-2-845]). Our recent published data however show that p38 and ERK2 are potent kinases for *in vitro* phosphorylation of S211 (located in AF1 domain) on the human GR ([@b67-btt-2-845]). The mutant lacking a phosphorylatable amino acid at position 211 (S221A) was considerably less potent in inducing the AF1-medited, GRE-driven reporter gene, and GR-mediated apoptosis induced by dexamethasone ([@b67-btt-2-845]). Garabedian and colleagues ([@b80-btt-2-845]; [@b7-btt-2-845]; [@b42-btt-2-845]; [@b46-btt-2-845]; [@b100-btt-2-845]) have also demonstrated that site-specific phosphorylation in GR, particularly S211 and S226 play an important role in gene regulation by the GR, and AF1 appears to be a main player in this process. Thus, in contrast to earlier study that suggested lack of specificity of phosphorylation ([@b1-btt-2-845]), these more recent findings clearly indicate the role of site-specific phosphorylation in AF1-mediated GR functions ([@b42-btt-2-845]; [@b67-btt-2-845]).

Role of phosphorylation in protein: protein interactions involving the GR and specific coregulators
===================================================================================================

In the conceptual model of a GR:coactivator complexes, the ligand-bound receptor recruits one or more coactivators, which subsequently results in the recruitment of additional coactivators to the assembly. The histone acetylation and methylation activities of various constituents of the coactivator complex facilitate the relaxation of the chromatin architecture at the target gene promoter, thereby enhancing transcriptional activation. Analogous arguments can be made for GR:corepressors complexes ([@b38-btt-2-845]; [@b110-btt-2-845]; [@b63-btt-2-845]). The GR AF1 domain is known to play an important role in many of these interactions, via interaction with regions of the coactivator remote from the LXXLL motif ([@b53-btt-2-845]). The ability of GR AF1 to interact with components of the general transcriptional machinery or with coregulator complexes provides a broad insight into the process of transcriptional initiation. CBP, TBP, AdA2, DRIP150, TSG101, and several other co-regulators have been shown to bind to the GR AF1 ([@b53-btt-2-845]; [@b42-btt-2-845]). Direct binding of TBP with AF1, raises the possibility that this GR domain somehow directly influences the transcriptional machinery. *In vitro* transcription studies indicated that the holo-GR acts to stabilize the pre-initiation complex ([@b38-btt-2-845]; [@b110-btt-2-845]; [@b63-btt-2-845]), though other mechanisms to control transcription have recently been reported ([@b32-btt-2-845]; [@b110-btt-2-845]; [@b29-btt-2-845]; [@b61-btt-2-845]).

It has been reported that the interaction between the GR and TSG101 may be modulated through GR phosphorylation ([@b43-btt-2-845]). This study shows that TSG101 is preferentially recruited to the nonphosphorylated form of the GR ([@b43-btt-2-845]). Another GR AF1 coregulator DRIP150 is also been reported to be modulated through GR phosphorylation ([@b42-btt-2-845]). Our unpublished data (Garza and Kumar, in preparation) show that interaction of several GR AF1 coregulators including TBP, CBP, and SRC-1 are facilitated by GR phosphorylation. Moreover, phosphorylation of several transcription factors, including NHRs enhances recruitment of coregulatory proteins ([@b107-btt-2-845]). Thus, it can be concluded that site-specific phosphorylation of the AF1 domain of GR can either enhance or diminish recruitment of coregulators.

These contrasting effects of AF1/GR phosphorylation on recruitment of specific coregulators may reflect the biologic need for the GR to up- or down-regulate gene(s) in a cell- and promoter-specific manner. Recent studies have shown that GR site-specific phosphorylation can differentially regulate the expression of several target genes ([@b16-btt-2-845]; [@b21-btt-2-845]; [@b8-btt-2-845]). However, this phenomenon is not clearly understood, and further studies are needed to provide a more comprehensive explanation for this behavior. One clue to the complexity of this system is that SG101 stabilizes ligand-unbound GR in its unphosphorylated form to protect it from degradation. Our recent findings (Garza and Kumar, in preparation) suggest that phosphorylation of the GR stabilizes the conformation of otherwise unstructured AF1 such that AF1's surfaces are available for its interaction with co-regulatory proteins. Thus, TSG101 interaction with GR may be important to keep unliganded GR protected from autodegradation until the GR becomes phosphorylated.

Recent studies suggest that in addition to the receptor phosphorylation, the activities and specificities of coregulators are also subject to similar regulation by phosphorylation. For example, the actions of coregulators including SRCs and CBP can be modified by phosphorylation ([@b97-btt-2-845]; [@b15-btt-2-845]; [@b28-btt-2-845]; [@b83-btt-2-845]; [@b60-btt-2-845]; [@b86-btt-2-845]; [@b77-btt-2-845]; [@b111-btt-2-845]; [@b17-btt-2-845]; [@b48-btt-2-845]; [@b14-btt-2-845]; [@b107-btt-2-845]). Several phosphorylation sites for SRC-1 and SRC-3 have recently been identified ([@b84-btt-2-845]; [@b108-btt-2-845]). Phosphorylation of these coregulators is induced by steroid hormones ([@b60-btt-2-845]; [@b108-btt-2-845], [@b107-btt-2-845]), and phosphorylation is critical for optimal activities. These data suggest that phosphorylation of coregulators may influence their protein-protein interactions with GR. This concept raised the possibility that the phosphorylation patterns of specific coregulator(s) might serve as a signal integrator, permitting this complex network of GR and cofactors to accurately and specifically activate a broad range of promoters for transcriptional activation.

Role of phosphorylation on the transactivation activity of the GR
=================================================================

It has been demonstrated that the status of GR phosphorylation can alter its transcriptional activity ([@b62-btt-2-845]). There are reports showing that in human GR S203A and/or S211A mutations significantly repress GR activity, whereas S226A mutation has increased GR activity in a yeast system ([@b1-btt-2-845]), suggesting that effects of phosphorylation on the GR transcriptional activity could be both up- or down-regulated depending upon the site of phosphorylation, and (due to site-specificity of the kinase) probably the specific kinase pathways involved ([@b42-btt-2-845]). Reduced GR activity and decreased level of phosphorylation status have been observed in cells deficient in the CDK inhibitor p27 ([@b81-btt-2-845]). However, other studies show that mutations of multiple GR phosphorylation sites do not significantly alter GRE-mediated GR activity in cell co-transfection studies (Almlof et al 1991). A number of explanations for these apparently conflicting results exist. For example, some studies were conducted using different promoters, and therefore it is quite possible that the influence of the GR phosphorylation on its transcriptional activation activity may be dependent on the promoter context of the target gene. It is also likely that site-specific phosphorylation of the GR would contribute to endogenous gene regulation, acting in a cell-type specific manner in which the use of kinases might differ ([@b112-btt-2-845]). Another possible explanation is that individual phosphorylation sites may influence translocation to the nucleus ([@b103-btt-2-845]). However, the presence of conflicting data ([@b100-btt-2-845]) highlights the complexity of this system, and the need for more studies to establish underlying mechanisms.

We have shown that a mutation of Ser211 to Ala residue reduced GR-mediated transcriptional activation and apoptosis in a human leukemia cell line, suggesting a role for p38 MAPK signaling in glucocorticoid-induced apoptosis of lymphoid cells. With respect to the consequences of p38 MAPK phosphorylation, it has further been shown that S211 residue of AF1 is a specific substrate site for p38 MAPK, and that mutation S211A, which prevents phosphorylation at this position, diminishes apoptosis driven by the constitutively active GR lacking the ligand binding domain, suggesting a possible role of AF1-mediated GR transcriptional activity ([@b67-btt-2-845]). However, it is not known whether other phosphorylation sites (eg, S203 and S226) are also involved in this process. Further studies in our laboratory are exploring a variety of possibilities to understand the role of phosphorylation in GR function. Similar effects have been shown in other laboratories, using different cells and kinase pathways ([@b42-btt-2-845]). Thus, in contrast to earlier study ([@b1-btt-2-845]), these recent findings clearly indicate the critical role of site-specific phosphorylation of AF1 in regulating GR functions. Activity of steroid bound GR may also be reduced due to site-specific phosphorylation ([@b42-btt-2-845]). For example, activation of JNK induces rat GR phosphorylation at S246 which significantly reduces GR activity; mutation of S246A, eliminating the potential phosphorylation site, diminishes inhibitory effects of JNK ([@b42-btt-2-845]). These results suggest that phosphorylation at S246 either increases its affinity for a corepressor or decreases its interaction with a coactivator. Thus, site-specific phosphorylation and the particular kinase pathways involved in different cell types may dictate the pattern of GR regulation of specific target gene(s). Further, these effects may be synergistic in nature.

Additional studies are needed to clarify the underlying mechanisms to determine these effects. A possible role of phosphatases has also been reported to regulate GR phosphorylation and its subsequent effects of the transcriptional activity ([@b42-btt-2-845]). Perturbations in protein phosphatase activity have been shown to affect GR function. Treatment of cells with protein phosphatase inhibitor results in enhanced phosphorylation of GR, accumulation of GR in the cytoplasm, and subsequent reduction in GR-mediated transcriptional activation ([@b23-btt-2-845]; [@b90-btt-2-845]). However, the effects of specific phosphatases (and by extension specific phosphatase inhibitor) on site-specific GR phosphorylation and function have not been well established. Collectively, the effect of phosphatases on GR signaling and transcriptional regulation is complex, and requires further examination. Thus, it becomes of great importance to determine the pattern, kinetics, extent, and effects of phosphorylation/dephosphorylation in modulating GR action. Subsequently, it will be critical to establish the mechanisms by which modulation of GR activity occurs, and determine whether AF1 phosphorylation, in a site-specific manner, is an integrating phenomenon for GR regulation. Although short of actual proof, it seems apparent that both kinases and phosphatases may be interacting in complex ways to determine phosphorylation of specific sites within the GR AF1 that may well be cell- and promoter-specific in nature.

Summary and perspectives
========================

Steroids have been frontline therapy for decades in the treatment of malignancies and inflammatory disorders; however the mechanism by which steroid receptors pass signals from ligand to regulate specific genes is not fully understood. Recent progress combined with classical understanding of the steroid receptors action, and the availability of the structure of individual domains of several members of the NHR superfamily including the GR has provided new understanding of the function of the GR. Recent studies have suggested that under physiological conditions, there are many factors that influence the conformation of the GR such that malleable protein surfaces are available for interaction with appropriate coactivators/corepressors. However, it remains to be determined how precisely these GR:protein interactions may differ with different cell- and promoter-specific conditions, and how the receptor communicates with transcription initiation machinery. Another important problem that remains to be solved is the precise mechanism by which AF1 and AF2 synergize with each other in the holo-receptor. Post-translational modifications including phosphorylation, ubiquitination, and sumoylation have all been shown to affect functions of NHR family members.

In recent years it has become clear that the cross-talk exists between GR signaling and other receptor cascades including inflammatory kinases (MAPKs, ERK, p38 and JNK) as well as the cAMP-driven PKA pathways. There is evidence that that differential phosphorylation is a potential regulator of species-specific actions of the GR. However, current knowledge reveals that the role of GR phosphorylation is a remarkably complex phenomenon. It is evident that the GR is a target for multiple kinases, and that many GR functions are regulated by phosphorylation. Several outstanding questions remain to be answered. For example: 1) what are the relative levels of phosphorylation of individual sites under physiological conditions; 2) how do phosphatases influence the cellular machinery; and 3) what is the correlation between cell based studies and *in vivo* animal models. However, it is clear that GR-mediated glucocorticoid signaling is a multifaceted process involving crosstalk with various regulatory kinase pathways. Thus, signaling cascades that induce phosphorylation of the GR and its coactivator proteins are critical factors in determining the physiological actions of the GR. Further studies that clarify the regulation of endogenous target genes by specific phosphorylation site(s) should lead to target- and perhaps tissue-specific requirements for phosphorylation. There are several other avenues of post-translational modifications that might also affect the actions of GR. Ubiquitination-mediated degradation regulates glucocorticoid signaling by controlling the degradation rates of GR ([@b47-btt-2-845]). Another post-translational modification, sumoylation, can also regulate the GR functions ([@b56-btt-2-845]). There are at least three known sumoylation sites in the human GR. Two of them are located in the NTD (K277 and K293) and one (K703) in the LBD ([@b27-btt-2-845]). Acetylation and methylation are other possible modifications that may influence GR actions; however, there is not enough evidence to suggest their direct role in modulating GR functions. At least one recent study has shown a ligand-dependent acetylation of the human GR at K494 and K495 residues, but the functional consequences of this modification are not clear ([@b44-btt-2-845]).

We propose that under physiological conditions, site-specific phosphorylation plays a crucial role in allowing the AF1 domain of the GR to adopt functionally active conformation(s) *in vivo* ([Figure 3](#f3-btt-2-845){ref-type="fig"}). The resulting structurally modified forms of AF1 suit it for its varied interactions with other critical coregulatory proteins, and possibly additional modulations in receptor structure essential for gene regulation by the GR. These interactions give a set of functionally active folded structure to AF1 and form the basis for the multiprotein assemblies involved in GR-mediated regulation of transcription. How site-specific phosphorylation leads to such AF1 conformation(s) and what kind of functional folded conformation it adopts are open questions, and we and others have been pursuing answers to these long-standing problems. Knowledge of the conformational changes in AF1 and/or other domains/regions of the GR due to site-specific phosphorylation and subsequently gene regulation will lead to an understanding of the role of this important phenomenon in the transcription process, information essential to understanding how glucocorticoids affect gene regulation.
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![Classical action of the glucocorticoid signaling mediated by the GR. Unliganded receptor is located in the cytosol associated with several heat shock and other chaperone proteins including HSP90, HSP70, CyP-40, P23, and FKBPs (shown by different shapes and shades in the cytosol). Ligand binding leads to conformational alterations in the GR, and by doing so GR dissociates from these associated proteins, and ligand bound GR is free to translocate to the nucleus. This process appears to be phosphorylation-dependent. Once in the nucleus, GR dimerizes and binds to site-specific DNA binding sequences and interacts with several other coregulatory proteins including coactivators and proteins from the basal transcription machinery including SRCs, CBP/p300, DRIP/TRAP, TBP, GRIP1, and several others (shown by different shapes and shades) in the nucleus, and subsequently leading to transcriptional regulation.](btt-2-845f1){#f1-btt-2-845}

![A topological diagram of the human GR (amino acids 1--777) showing its modular structure and known phosphorylation sites in it (based on ref. 38). Numbers on the bottom indicate amino acid positions of different functional domains. 1--420, NTD; 77--262, AF1; 421--481; DBD; and remaining C-terminal part, the LBD are shown. P denotes known phosphorylation sites in the NTD of the human GR. Shown from left to right: S113, S141, S203, S211, S226, and S308. Corresponding amino acids in the rat GR are S134, S162, S224, S232, S246, and S329, whereas in the mouse GR these correspond to S122, S150, S212, S220, S234, and S315. In the rat and mouse GR, there is one Threonine residue (T171 in rat and T159 in mouse) that is known to be phosphorylable, and is not conserved in the human GR. In the human GR except for S308, all other residues are located within the AF1 domain, and S203, S211, and S226 are reported to have to have some functional roles in the action of the GR. Phosphorylation of these sites are kinase- and cell-dependent.](btt-2-845f2){#f2-btt-2-845}

![A hypothetical model of the role of site-specific phosphorylation on the structure and functions of the AF1 domain. The GR AF1 domain exists in an intrinsically disordered (ID) conformation ie, as an ensemble of conformers that collectively appear to lack any significant secondary/tertiary structure. Phosphorylation of one or more sites within the AF1 alters its conformation in such a way that AF1 adopts a partially folded (PD) conformation that facilitates AF1's interaction with one or more of the coregulatory proteins. This protein:protein interaction allows structurally modified forms of AF1 to suit for its varied interactions with other critical coregulatory proteins, and possibly additional modulations in receptor structure essential for gene regulation by the GR. This AF1:coregulators assembly provides optimal ordered conformation in the AF1 for subsequent transactivation activity. Alternatively, one or more of the coregulator proteins directly interact with one or more unphosphorylated AF1 conformers that may trigger phosphorylation of AF1. The resultant assembly of proteins may depend upon the cellular environment, specific promoters used, and the kinase pathway involved. All the available phosphorylation sites in the GR could be involved simultaneously or there may be a coordinated synergy between each site. In the full length GR, AF1:coregulators assembly may also be influenced by other factors such as DNA binding to its DBD, ligand binding and the cross talk between AF1 and AF2. In addition to the level of AF1 phosphorylation, phosphorylation of different coregulators may also influence the outcome, and certain coregulators may be included or excluded from the assembly depending upon the interacting surfaces of the AF1 and/or coregulator proteins.](btt-2-845f3){#f3-btt-2-845}
